Huang reported that the presence of the hyper-enhanced rim on the Kupffer phase images obtained from Sonazoid-contrast-enhanced ultrasound (Sonazoid-CEUS) is a promising biomarker to predict unfavorable response with anti-PD-1/PD-L1 therapy in HCC patients (18). This evidence concerns the gene PDCD1 and hepatocellular carcinoma.